Overview

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

Status:
Completed
Trial end date:
2018-03-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the efficacy of Aricept in patients with dementia with Lewy bodies (DLB).
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Donepezil